James L. Mohler, MD, on Prostate Cancer: Management Approaches
NCCN 2018 Annual ConferenceJames L. Mohler, MD, of Roswell Park Cancer Institute, discusses personalized medicine, molecular risk stratification, and better androgen-deprivation therapy for men with prostate cancer.
Related Videos
Ellin Berman, MD, on CML: Disease Management During Pregnancy
Ellin Berman, MD, of Memorial Sloan Kettering Cancer Center, discusses the effects of TKI therapy on fetal development, its impact on pregnancy outcomes, and how to develop an effe...
Anne M. Covey, MD, on HCC: Screening and Diagnosis Updates
Anne M. Covey, MD, of Memorial Sloan Kettering Cancer Center, discusses the latest recommendations for screening and diagnosing hepatocellular carcinoma, an aggressive tumor marked...
William J. Gradishar, MD, on Hormone-Sensitive Breast Cancer: Treatment Update
William J. Gradishar, MD, of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, discusses recent evidence on the efficacy, safety, and utility of HER2-targ...
Anthony D. Elias, MD, on Triple-Negative Breast Cancer: Treatment Update
Anthony D. Elias, MD, of the University of Colorado Cancer Center, reviews promising experimental treatments, as well as PARP inhibitor therapy in TNBC, including the implications ...
April K.S. Salama, MD, on Melanoma: Treating Recurrent or Progressive Distant Disease
April K.S. Salama, MD, of Duke Cancer Institute, talks about how to select systemic therapy for a patient with previously treated metastatic melanoma.
